𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SUCCESSFUL TREATMENT OF RESISTANT CYTOMEGALOVIRUS DUE TO UL97 AND UL54 MUTATIONS WITH HIGH-DOSE VALGANCICLOVIR

Book ID
122113285
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
217 KB
Volume
63
Category
Article
ISSN
0272-6386

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytomegalovirus antiviral resistance ass
Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations
✍ G.M. Scott; M.A. Isaacs; F. Zeng; A.M. Kesson; W.D. Rawlinson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract HCMV‐related illness due to infections with antiviral resistant virus was verified by phenotypic and genotypic assays in 17% (8/47) of high‐risk immunocompromised Australian patients. Selective PCR‐sequencing of UL97 (protein kinase; PK) and UL54 (DNA polymerase; DNApol) regions importa

Case Report: Persistent cytomegalovirus
Case Report: Persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes
✍ Kumi Oshima; Yoshinobu Kanda; Shinichi Kako; Yuki Asano-Mori1; Takuro Watanabe; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

## Abstract Addition of in vivo alemtuzumab to the conditioning regimen enabled 2‐ or 3‐locus‐mismatched hematopoietic stem cell transplantation with an acceptable incidence of graft‐versus‐host‐disease. However, the procedure was associated with a high incidence of cytomegalovirus (CMV) reactivati